Granting Restricted Stock Compensation
First written in FY2021-Q2. 5 of 8 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「20 February 2026 (Note 1) 52,400 60,487,600 19,230 5,530,430 19,230 5,335,499 (Note 1) Issuance of new shares for the grant of restricted stock: issue price, ¥734 per share; amount included in capital, ¥367 per share; allottees, 5 directors excluding outside directors and 26 executive officers.」
On 20 February 2026, 52,400 restricted shares were issued to 5 directors and 26 executive officers. - FY2025-H1AdvancedAnnual report
「Issuance of new shares for the grant of restricted stock: issue price, ¥1,031 per share; amount included in capital, ¥515.5 per share; allottees, 5 directors excluding outside directors and 23 executive officers.」
On 21 February 2025, 30,500 restricted shares were issued to 5 directors and 23 executive officers. - FY2024-Q2AdvancedAnnual report
「Issuance of new shares for the grant of restricted stock: issue price, ¥605 per share; allottees, 4 directors excluding outside directors and 23 executive officers.」
On 22 February 2024, 47,700 restricted shares were issued to 4 directors and 23 executive officers. - FY2023RestatedAnnual report
「We grant restricted stock compensation as share-based compensation in the form of non-monetary remuneration.」
The restricted stock compensation plan for directors and executive officers continued, with a total of 53,200 shares granted on 24 February 2023. - FY2023-Q2AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors meeting held on 24 January 2023, we issued new shares as restricted stock compensation on 24 February 2023, as follows: Directors: 4 people, 25,100 shares; Executive Officers: 23 people, 28,100 shares; transfer restriction period: 24 February 2023 to 31 May 2026.」
A total of 53,200 shares were granted to 4 directors and 23 executive officers, subject to transfer restrictions through 31 May 2026. - FY2022-Q2AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors meeting held on 18 January 2022, we issued new shares as restricted stock compensation on 18 February 2022, as follows: Directors: 4 people, 26,200 shares; Executive Officers: 22 people, 23,300 shares; transfer restriction period: 18 February 2022 to 31 May 2025.」
A total of 49,500 shares were granted to 4 directors and 22 executive officers, subject to transfer restrictions through 31 May 2025. - FY2021RestatedAnnual report
「We grant restricted stock compensation as share-based compensation in the form of non-monetary remuneration.」
The restricted stock compensation plan for directors and executive officers continued, with 36,100 shares granted on 19 February 2021. - FY2021-Q2First statedAnnual report
「Pursuant to a resolution of the Board of Directors meeting held on 19 January 2021, we issued new shares as restricted stock compensation on 19 February 2021, as follows: Directors: 4 people, 20,300 shares; Executive Officers: 21 people, 15,800 shares; transfer restriction period: 19 February 2021 to 18 February 2024.」
Restricted stock compensation for 4 directors and 21 executive officers was disclosed for the first time, involving a total grant of 36,100 shares subject to transfer restrictions through 18 February 2024.